Biognosys;biofluid proteomics biomarkers;Plasma;Cytokines;Chemokines;Lung Cancer
-
Health News
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
[ad_1] Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics…
Read More »